Key Segments:
By Device Type
-
Centrifugation-Based Devices
-
Microfluidic Chip-Based Devices
-
Swim-Up Devices
-
Other Device Types
By Technology
-
Density Gradient Centrifugation
-
Swim-Up Technique
-
Electrophoresis-Based Separation
-
Microfluidic/On-Chip Technology
By End User
-
Fertility Centers & IVF Laboratories
-
Hospitals & Diagnostic Centers
-
Cryobanks & Sperm Banks
-
Research & Academic Institutes
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The market includes CooperSurgical, Hamilton Thorne, NidaCon International AB, Bonraybio Co., Ltd., Memphasys, Lotus Bio Ltd., Vitrolife Group, and Fujifilm Irvine Scientific among others. These companies compete on separation method, clinical validation and laboratory service support.
The main opportunities lie in equipping consolidating fertility-clinic networks with standardized platforms and in cross-border partnerships that pair separation devices with established IVF consumable distribution. Expansion into underserved fertility markets adds further potential.
The key growth factor is the combination of rising male-factor infertility and expanding global IVF laboratory capacity, which together increase the number of cycles requiring a dedicated sperm separation step.
By device type, the Centrifugation-Based Devices segment dominated the market with approximately 54.80% share in 2025, supported by decades of established laboratory workflow and broad distributor availability.
North America dominated the market with approximately 37.20% share in 2025, supported by a dense fertility-clinic network and early access to FDA-cleared separation technologies. Asia Pacific is the fastest-growing region with a projected CAGR of 16.80% from 2026 to 2035.
